Skip to content

Quality of life among women with cancer cervix receiving brachytherapy as a part of treatment in a selected cancer care centre in North east India.

A study to assess the quality of life (QOL) among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment in a selected cancer care centre, North east India. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/096862
Enrollment
40
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Dr. B Borooah Cancer Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with cervical cancer and undergoing brachytherapy as a part definitive radiation therapy Patients on follow-up who had completed brachytherapy within the last 3 months. Adults aged 18 years and above, regardless of menopausal status. Patients who are willing to participate in the study. Patients who can understand English, Hindi or Assamese.

Exclusion criteria

Exclusion criteria: Patients with severe co-morbidities such as advanced cardiovascular disease, uncontrolled diabetes, or chronic kidney/liver failure that could independently affect quality of life (QoL) and functionality.

Design outcomes

Primary

MeasureTime frame
To determine the quality of life among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment.Timepoint: At 4 weeks of conclusion of brachytherapy

Secondary

MeasureTime frame
To find the correlation between the quality of life & the selected demographic variablesTimepoint: At 8 weeks of conclusion of the sample collections

Countries

India

Contacts

Public ContactDr Yanpothung Yanthan

Dr. Bhubaneswar Borooah cancer Institute

yanyanthan@gmail.com9612551001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026